Clinical pharmacy specialist implementation of lisinopril therapy in patients with coronary artery disease and diabetes mellitus.

Item

http://www.wikidata.org/entity/Q44705824

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Clinical pharmacy specialist i ...... disease and diabetes mellitus.

@en

Clinical pharmacy specialist i ...... disease and diabetes mellitus.

@nl

type

Item

label

Clinical pharmacy specialist i ...... disease and diabetes mellitus.

@en

Clinical pharmacy specialist i ...... disease and diabetes mellitus.

@nl

prefLabel

Clinical pharmacy specialist i ...... disease and diabetes mellitus.

@en

Clinical pharmacy specialist i ...... disease and diabetes mellitus.

@nl

P1476

Clinical pharmacy specialist i ...... disease and diabetes mellitus.

@en

P2093

Clinical Pharmacy Cardiac Risk Service Study Group

http://www.w3.org/2001/XMLSchema#string

John A Merenich

http://www.w3.org/2001/XMLSchema#string

Karen J McConnell

http://www.w3.org/2001/XMLSchema#string

Marsha A Raebel

http://www.w3.org/2001/XMLSchema#string

Tammy L Humphries

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP)

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

Optimizing treatment of dyslipidemia in patients with coronary artery disease in the managed-care environment (the Rocky Mountain Kaiser Permanente experience).

Effect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction: data from the GISSI-3 study.

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.

P304

1564-1572

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1592/PHCO.23.15.1564.31963

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2003-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14695037

http://www.w3.org/2001/XMLSchema#string